Publication | Closed Access

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience

Hematological MalignancyOncologyHematologySubsequent ThalidomidePathologyMyeloid NeoplasiaNewly-diagnosed Multiple MyelomaMedicineRadiation OncologyChinese ExperienceHealth Sciences